Navigation Links
2011 Proves Positive for UBM Live's Portfolio of Indian Pharma Events

AMSTERDAM, March 22, 2012 /PRNewswire/ -- Leading events organiser UBM Live, a division of UBM Plc (LSE: UBM), today announced that its India Pharma portfolio of events had a strong year in 2011. There was a positive growth in attendance figures over last year's Pharma events in Mumbai. Hosted from 30th November to 2nd December, 2011 at the Bombay Exhibition Centre, the line-up featured CPhI India for pharmaceutical ingredients, P-MEC India for pharmaceutical equipment, machinery and technology, ICSE India for contract services, clinical trials, and CROs and the BioPh trail for the biopharma market. Over three days, the events hosted 825 exhibitors from 21 different countries with an attendance of 27,437 people from 96 countries across the globe.

CPhI India and co-located events had top level exhibitor attendance from key industry companies such as BASF India, Lupin, Piramal Healthcare, Merck, SGS Life Science, and Aurobindo Pharma in 2011. The events were run in a traditional exhibition format with a complementary programme of networking and educational events run daily. New features included an exhibition tent in the parking area that acted as an extension of the venue and hosted over 100 new exhibitors. Returning features included the second year of the Conference Sessions which had strong attendance and covered hot industry topics such as Global Clinical Trials; Global Biosimilars Regulations; Healthcare and OTC Drugs; Developing Difficult Generics; Export Potential; and Competitive API Strategies. 

The Indian pharma market offers a unique business environment due to various factors including low cost of R&D and production, cutting edge technologies, and a well-educated and innovative work force. As the Indian pharma market grows, a focus is being placed on expansion through strategic investments and partnerships globally. Echoing this focus, CPhI India and co-located events were inaugurated by Martin O'Malley, Governor of Maryland, who came to Mumbai with a full delegation and plans to discuss how the Indian Government and Maryland can partner to support the pharma industry in Maryland.

"Our events have grown with this market organically. Especially over the past five years, we have seen India become the fourth largest pharma market globally and it is exciting to see the progress," noted Greg Kerwin, UBM Pharma Portfolio Director. He continued, "We are pleased to see that our customer base continues to grow and has positive feedback about the impact that the India pharma events have on their business. We work very hard to ensure that the events facilitate maximum exposure across the various sectors of the Indian Pharma market."

New exhibitor, Technoflex, confirmed that they saw immediate results from the event. Sylvie Ponlot, Communication Manager for the company commented, "This was our first CPhI India in Mumbai. We made contact with many new prospective clients and several customers. We strongly believe that new projects will result from our attendance. This was a really fruitful show for Technoflex and we will definitely be in Mumbai next year."

CPhI India, ICSE and P-MEC India will return to the Bombay Exhibition Centre in Mumbai from 21-23 November 2012. To learn more about CPhI India, please visit:

UBM's market leading schedule of annual pharma events also includes Japan (21-23 March, 2012, Tokyo Big Sight Exhibition Centre, Japan), South East Asia (10-12 May, 2012, Jakarta International Expo, Indonesia), ICSE USA (22-23 May, 2012, Pennsylvania Convention Centre, Philadelphia), China (26-28 June, 2012, SNIEC, Shanghai, China), South America (21-23 August, 2012, Transamerica Expo Centre, Brazil) and Worldwide (9-11 October, 2012 at the Feria de Madrid, Spain).

Notes for Editors:

UBM Live is a division of UBM Plc (LSE: UBM) a leading provider of business information services to the maritime, travel, fashion, technology, healthcare, media, and property industries. UBM offers services in trade shows, online, news distribution, and publishing to customers across the globe. Its brands are represented in more than 30 countries and are organized into specialist teams that serve their business communities helping them excel in their market by working effectively and efficiently. For more information, go to

Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. U.S. FDA Approves First and Only Oral Contraceptive Demonstrated to Treat Heavy Menstrual Bleeding (HMB)
2. FDA Approves Additional Manufacturer of Methoxsalen
3. Axion Healths ReadySet Software Proves Web-Based Electronic Health Records (EHR) Reduce Clinical Errors and Increase Compliance
4. FDA Approves New Skin Cancer Drug First Tested in Arizona by Scottsdale Healthcare and TGen
5. FDA approves Novartis drug Gleevec® label recommending extending treatment to three years for certain GIST patients after surgery
6. FDA Approves Gleevec For Expanded Use in Patients With Rare Gastrointestinal Cancer
7. FDA Approves Kalydeco to Treat Rare Form of Cystic Fibrosis
8. ASAM Approves Prescription Drug Policy
9. FDA Approves Picato® (ingenol mebutate) Gel, the First and Only Topical Actinic Keratosis (AK) Therapy With 2 or 3 Consecutive Days of Once-Daily Dosing
10. FDA Approves Shared REMS (Risk Evaluation and Mitigation Strategy) Program for all TIRF (Transmucosal Immediate Release Fentanyl) Pain Treatments
11. FDA Approves EDARBYCLOR (azilsartan medoxomil and chlorthalidone) for the Treatment of Hypertension
Post Your Comments:
(Date:11/30/2015)... , Nov. 30, 2015 NHS Supply ... 20 TrueBeam™ machines from Varian Medical Systems (NYSE: ... program to replace older machines and institute modern ... UK,s public hospitals. The order, placed in September, ... licenses for Varian,s RapidArc® and Eclipse™ software systems.    ...
(Date:11/30/2015)... , Nov. 30, 2015  Hanger, Inc. (NYSE: ... restatement of the terms of its previously announced consent ... to its $200,000,000 aggregate principal amount 7⅛% Senior Notes ... (i) the consent fees payable pursuant to the Consent ... Notes and (iii) the expiration date of the Consent ...
(Date:11/30/2015)... , Nov. 30, 2015  Precision Image ... services, is pleased to announce a dramatic expansion ... imaging services. Building on its ISO-9001:2008 certification for ... implemented comprehensive Core Lab protocols and procedures. This ... of research activities.  Their Core Lab services include ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... November 30, 2015 , ... Holcomb – Kreithen ... plastic surgery practices in Florida, is proud to announce that Dr. Joshua Kreithen, ... giant Ethicon Inc., a Johnson & Johnson Company. , Ethicon is a global ...
(Date:11/30/2015)... EMIGSVILLE, PA (PRWEB) , ... November 30, 2015 ... ... (CCMS) software provider, has verified that their Vasont Universal Integrator (VUI) extension unites ... handle creating, editing, and managing content as a continuous process with the latest ...
(Date:11/30/2015)... Maryland (PRWEB) , ... November 30, 2015 , ... ... interactions could be of critical importance to the medical schools of the future. ... exhibited its healthcare suite at the 2015 ChangeMedEd conference in Chicago, organized by ...
(Date:11/30/2015)... ... 30, 2015 , ... Innovaacom, a leading provider of medical ... survey of educational needs for pharmacists worldwide. The poll of pharmacists in Europe, ... quality online and face-to-face education for pharmacists who are fast becoming the new ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... In 2016, expected coding changes are likely to include new codes for spine ... not easy to understand the effects of code changes in musculoskeletal, radiology and ...
Breaking Medicine News(10 mins):